首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands
【2h】

Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands

机译:Cyclostreptin-Tubulin加合物的晶体结构:紫杉烷-站点配体激活微管蛋白的含义。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands.
机译:已经提出,紫杉烷位点配体介导的微管蛋白活化的机制之一是调节开关元件(M-环)的结构,从二聚体微管蛋白中的无序形式到微管中的折叠螺旋结构。在这里,我们使用了共价紫杉烷位配体,包括环链素,以进一步了解这种机制。结合环链素的微管蛋白的晶体结构显示出与βHis229的共价结合,但M环未稳定。与其他共价紫杉烷位点试剂相比,环链素诱导微管装配的能力表明,微管蛋白装配的诱导并不严格依赖于M环的稳定。我们进一步证明,大多数共价紫杉烷位点配体能够部分克服HeLa细胞中由βIII-微管蛋白(βIII)过度表达介导的耐药性,并将它们的活性与微管蛋白组装体的界面共价抑制剂pironetin进行比较,该抑制剂在生长中表现出不变的生长抑制作用。这些细胞。我们的发现表明,紫杉烷类位点配体与βIII-微管蛋白的相互作用减少和βIII微管蛋白介导的耐药性之间存在关联。这支持以下观点:βIII的过表达通过抵消由共价紫杉烷-位点结合配体促进的增强的微管稳定性来增加微管动态性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号